Tumor necrosis factor genomic polymorphism in Spanish IGA deficiency patients

Tissue Antigens

Volumn 55, Issue 4, 2000, Pages 359-363

  De la Concha, Emilio Gómez ^a   Fernandez Arquero, M ^a   Vigil, P ^a   Lazaro, F ^a   Ferreira, A ^b   Garcia Rodriguez, M C ^b   Fontan, G ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Gene association; HLA; IgA deficiency; TNF

Indexed keywords

IMMUNOGLOBULIN A; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SPAIN;

ALLELES; GENE FREQUENCY; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; IGA DEFICIENCY; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SPAIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034018120     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550410.x     Document Type: Article

References (25)

1. 1. Hammarström L, Smith CI. HLA-A, B, C and DR antigens in immunoglobulin A deficiency. Tissue Antigens 1983: 21: 75-9.
2. 2. Olerup O, Smith C, Hammarstrom L. Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency. Nature 1990: 347: 289-90.
3. 3. Olerup O, Smith C, Bjorkander J, Hammarstrom L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci U S A 1992: 89: 10653-7.
4. 4. French MA, Dawkins RL. Central MHC genes, IgA deficiency and autoimmune diseases. Immunol Today 1990: 11: 271-4.
5. 5. Schaffer F, Palermos J, Zhu Z, Barger B, Cooper M, Volanakis J. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci U S A 1989: 86: 8015-9.
6. 6. Volanakis J, Zhu Z, Schaffer F et al. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Invest 1992: 89: 1914-22.
7. 7. Schroeder HW, Zhu Z-B, March RE et al. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med 1998: 4: 72-86.
8. 8. Vorechovsky I, Webster AD, Plebani A, Hammarstrom L. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 1999: 64: 1096-109.
9. 9. Reil A, Bein G, Machulla HK, Sternberg B, Seyfarth M. High-resolution DNA typing in immunoglobulin A deficiency confirms a positive association with DRB1*0301, DQB1*02 haplotypes. Tissue Antigens 1997: 50: 501-6.
10. 10. Clerici N, Fernandez M, Saiz I, Sainz T, Polanco I. Human leukocyte antigen alleles and haplotypes associated with selective immunoglobulin A deficiency in Spanish pediatric patients. J Pediatr Gastroenterol Nutr 1993: 16: 381-6.
11. 11. Cuccia-Belvedere M, Monafo V, Martinetti M, Plebani A, De Paoli F, Burgio GR. Recurrent extended HLA haplotypes in children with selective IgA deficiency. Tissue Antigens 1989: 34: 127-32.
12. 12. Fiore M, Pera C, Delfino L, Scotese I, Ferrara GB, Pignata C. DNA typing of DQ and DR alleles in IgA-deficient subjects. Eur J Immunogenet 1995: 22: 403-11.
13. 13. Degli-Esposti MA, Leelayuwat C, Daly LN et al. Updated characterization of the Fourth Ancestral Haplotypes using Asia-Oceania Histocompatibility Workshop panel. Hum Immunol 1995: 44: 12-8.
14. 14. Pasparakis M, Alexopoulou L, Episkopou V, Kolias G. Immune and inflammatory responses in TNF-α-deficient mice: A critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the immune response. J Exp Med 1996: 184: 1397-411.
15. 15. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 1997: 6: 491-500.
16. 16. Makhatadze NJ. Tumor necrosis factor locus: genetic organisation and biological implications. Hum Immunol 1998: 59: 571-9.
17. 17. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997: 94: 3195-9.
18. 18. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994: 371: 508-10.
19. 19. Brinkman BM, Huizinga TW, Kurban SS et al. Tumor necrosis factor alpha gene polymorphism in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997: 36: 516-21.
20. 20. Fernandez-Arquero M, Arroyo R, Rubio A et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 1999: 53: 1361-3.
21. 21. Moghaddam PH, de Knijff P, Schipper RF et al. Selective co-evolution of the D6STNFa microsatellite region with HLA class I and II loci. Tissue Antigens 1998: 52: 213-9.
22. 22. Mulcahy B, Waldoron-Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996: 59: 676-83.
23. 23. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/ lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-β) gene. J Immunol 1991: 147: 1053-9.
24. 24. Primary immunodeficiency diseases. Report of a WHO Scientific Group. Clin Exp Immunol 1997: 109 (Suppl 1): 1-28.
25. 25. De la Concha EG, Arroyo R, Crusius JBA et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/ remitting multiple sclerosis. J Neuroimmunol 1997: 80: 172-8.